Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) through any online brokerage.
Other companies in Madrigal Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ascentage Pharma Group (NASDAQ:AAPG).
Madrigal Pharmaceuticals has a consensus price target of $350.71.
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $336.23 last updated February 21, 2025 at 4:00 PM EST.
There are no upcoming dividends for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Madrigal Pharmaceuticals.
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.